{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:42:02Z","timestamp":1772131322941,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2019JJ60084"],"award-info":[{"award-number":["2019JJ60084"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Percutaneous coronary intervention (PCI) has become one of the effective methods for the treatment of coronary heart disease (CHD). However, it is easy to have in-stent restenosis (ISR), even cardiovascular events after PCI, which affects the therapeutic effects. The incidence of ISR in diabetes mellitus (DM) patients increased by 2 to 4 times. Early identification of the risk factors of ISR in DM patients after PCI may help clinical staff to prevent and intervene as soon as possible, so it is very important to improve the clinical outcomes of DM patients. Although scholars at home and abroad have studied and summarized the risk factors of ISR in DM patients after PCI, the conclusions are different. Therefore, in this study, meta-analysis was used to summarize the risk factors of ISR in DM patients after PCI, and to explore the characteristics of high-risk groups of ISR, thus providing reference for early identification and prevention of ISR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We will search related literature from PubMed, Embase, Cochrane Library, Web of Science, China Biology Medicine Database, China National Knowledge Infrastructure, China Science and Technology Journal Database, and Wanfang Database. Eligible studies will be screened based on inclusion criteria. Meanwhile, data extraction, risk of bias assessment, publication bias assessment, subgroup analysis, and quality assessment will be performed. Review Manager Version 5.3 software will be applied for data analysis. Each process is independently conducted by 2 researchers. If there is any objection, it will be submitted to a third researcher for resolution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We will disseminate the findings of this systematic review and meta-analysis via publications in peer-reviewed journals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The results of this analysis can be used to generate a risk prediction model and provide an intervention strategy for the occurrence of ISR in DM patients after PCI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OSF REGISTRATION NUMBER:<\/jats:title>\n            <jats:p>DOI 10.17605\/OSF.IO\/WC87Y.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025484","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T21:50:38Z","timestamp":1618350638000},"page":"e25484","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention"],"prefix":"10.1097","volume":"100","author":[{"given":"Suiping","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-6291","authenticated-orcid":false,"given":"Haimei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhuzhou Central Hospital, Zhuzhou 412000, Hunan Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"e039405","DOI":"10.1136\/bmjopen-2020-039405","article-title":"Associations of myeloperoxidase, interleukin-17A and heparin-binding EGF-like growth factor levels with in-stent restenosis after percutaneous coronary intervention: a single-centre case\u2013control study in China","volume":"10","author":"Jiang","year":"2020","journal-title":"BMJ Open"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2017.02.061","article-title":"Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease","volume":"236","author":"Kurtul","year":"2017","journal-title":"Int J Cardiol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R5-20250504","first-page":"1142","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"39","author":"Stone","year":"2004","journal-title":"Acc Curr J Rev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ahj.2005.01.050","article-title":"Full metal jacket\u201d (stented length \u226564\u200amm) using drug-eluting stents for de novo coronary artery lesions","volume":"150","author":"Aoki","year":"2005","journal-title":"Am Heart J"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00059-018-4777-0","article-title":"Coronary restenosis","volume":"44","author":"Zotz","year":"2019","journal-title":"Herz"},{"key":"R8-20250504","first-page":"417","article-title":"Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?","volume":"43","author":"Gen\u00e7bay","year":"2015","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCIMAGING.112.976167","article-title":"Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry","volume":"5","author":"Yonetsu","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacl.2015.10.009","article-title":"Prevalence of dyslipidemia and its control intype 2 diabetes: a multicenter study in endocrinology clinics of China","volume":"10","author":"Li","year":"2016","journal-title":"J Clin Lipidol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ahj.2007.06.005","article-title":"Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era","volume":"154","author":"Iijima","year":"2007","journal-title":"Am Heart J"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12872-016-0445-6","article-title":"Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis","volume":"17","author":"Zhao","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCA.0b013e328340b210","article-title":"Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents","volume":"22","author":"Park","year":"2011","journal-title":"Coron Artery Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e72710","DOI":"10.1371\/journal.pone.0072710","article-title":"The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis","volume":"8","author":"Qin","year":"2013","journal-title":"PLoS One"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"a1331","DOI":"10.1136\/bmj.a1331","article-title":"Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis","volume":"337","author":"Stettler","year":"2008","journal-title":"BMJ (Clinical research ed)"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/hrt.2005.070698","article-title":"Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials","volume":"92","author":"Stettler","year":"2006","journal-title":"Heart (British Cardiac Society)"},{"key":"R17-20250504","first-page":"28","article-title":"In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: clinical presentation, angiographic features, and outcomes","volume":"23","author":"Paramasivam","year":"2020","journal-title":"Anatol J Cardiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4103\/0366-6999.228247","article-title":"Platelet distribution width on admission predicts in-stent restenosis in patients with coronary artery disease and type 2 diabetes mellitus treated with percutaneous coronary intervention","volume":"131","author":"Hu","year":"2018","journal-title":"Chin Med J"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-020-01111-7","article-title":"Visit-to-visit HbA(1c) variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention","volume":"19","author":"Yang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"R20-20250504","first-page":"137","article-title":"New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent","volume":"15","author":"Wang","year":"2018","journal-title":"J Geriatr Cardiol"},{"key":"R21-20250504","first-page":"1494","article-title":"Correlation analysis of CTRP3 and FGF21 on coronary in-stent restenosis in patients with diabetes mellitus after PCI","volume":"35","author":"Zeng","year":"2020","journal-title":"J Pract Med"},{"key":"R22-20250504","first-page":"1821","article-title":"Study on predictors of in-stent restenosis in patients with diabetes mellitus after PCI","volume":"23","author":"Wang","year":"2019","journal-title":"Anhui Med Pharm J"},{"key":"R23-20250504","first-page":"613","article-title":"Evaluation of the SYNTAX score on the coronary in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent","volume":"36","author":"Qin","year":"2017","journal-title":"J Cardiovasc Pulm Dis"},{"key":"R24-20250504","first-page":"g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ (Clinical research ed)"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clinical research ed)"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00059-012-3602-4","article-title":"Coronary revascularization in diabetic patients. A focus on the 3-year SYNTAX trial outcomes","volume":"37","author":"Groot","year":"2012","journal-title":"Herz"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0735-1097(02)01969-1","article-title":"Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery","volume":"40","author":"Carson","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/030006059502300613","article-title":"Insulin secretion levels necessary for efficacy of an alpha-glucosidase inhibitor on glucose metabolism in patients with non-insulin-dependent diabetes mellitus","volume":"23","author":"Okada","year":"1995","journal-title":"J Int Med Res"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.carrev.2019.03.001","article-title":"Outcomes with drug-coated balloons in percutaneous coronary intervention in diabetic patients","volume":"21","author":"Megaly","year":"2020","journal-title":"Cardiovasc Revasc Med: including molecular interventions"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/1932296813517058","article-title":"Percutaneous coronary intervention in patients with diabetes: current concepts and future directions","volume":"8","author":"Armstrong","year":"2014","journal-title":"J Diabetes Sci Technol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:46:42Z","timestamp":1746337602000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025484"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":32,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025484","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"2021-03-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}